| Dose Ranging Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Rectal Foam in Pediatric Patients Aged 5 to 17 Years With Active, Mild to Moderate Distal Ulcerative Colitis (NCT05976802) | Bausch Health Americas, Inc. | 2027-06-01 |
| Efficacy and Safety of Bupropion Hydrobromide in Adolescents and Children With Major Depressive Disorder (NCT02129751) | Bausch Health Americas, Inc. | 2026-06-01 |
| This is a Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study of the Efficacy and Safety of 2 Weight-based Treatment Groups of Plecanatide Versus Placebo in Children and Adolescent Participants 6 to Less Than 18 Years of Age With FC (NCT07723924) | Bausch Health Americas, Inc. | 2026-06-01 |
| Study to Assess Safety, Pharmacokinetics, and Treatment Effect of Cabtreo (NCT07524946) | Bausch Health Americas, Inc. | 2026-04-01 |
| Rifaximin 200 mg Plus Oral Rehydration vs Oral Rehydration Alone in Children With Acute Diarrhea (NCT07285785) | Bausch Health Americas, Inc. | 2026-02-11 |
| Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH) (NCT07428538) | Bausch Health Americas, Inc. | 2026-01-29 |
| A Prospective Controlled Study to Evaluate the Safety and Effectiveness of Thermage® FLX Radiofrequency Treatment (NCT07187297) | Bausch Health Americas, Inc. | 2025-10-31 |
| A Phase 4 Clinical Study to Investigate the Effectiveness and Safety of Skin Resurfacing (NCT07214272) | Bausch Health Americas, Inc. | 2025-10-17 |
| Clindamycin Phosphate, Adapalene, and Benzoyl Peroxide Triple Combination Gel in Canadian Patients With Acne Vulgaris (NCT07205107) | Bausch Health Americas, Inc. | 2025-10-02 |
| Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Extended-release Tablets in Pediatric Subjects Aged 5 to 17 Years With Active, Mild to Moderate Ulcerative Colitis (NCT04314375) | Bausch Health Americas, Inc. | 2023-09-29 |
| Evaluation of Rifaximin SSD for Delaying Encephalopathy Decompensation in Patients With Cirrhosis (NCT05297448) | Bausch Health Americas, Inc. | 2022-08-03 |
| Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis (NCT05071716) | Bausch Health Americas, Inc. | 2022-04-07 |
| Pharmacokinetics and Pharmacodynamics of Rifaximin Novel Formulations in Patients With Sickle Cell Disease (NCT05098028) | Bausch Health Americas, Inc. | 2022-03-22 |
| Safety and Effectiveness of the CLEAR + BRILLIANT TOUCH(R) Diode Laser 1440-nm and 1927-nm Combination Wavelength Treatment (NCT05027282) | Bausch Health Americas, Inc. | 2021-10-27 |
| Canadian Real World Evidence Study of Brodalumab in Plaque Psoriasis to Understand the Impact on Quality of Life and Work Productivity (NCT05132231) | Bausch Health Americas, Inc. | 2021-10-22 |
| Study Evaluating Efficacy and Safety of Amiselimod (MT-1303) in Mild to Moderate Ulcerative Colitis (NCT04857112) | Bausch Health Americas, Inc. | 2021-09-29 |
| Study to Compare the Safety and Efficacy of IDP-126 Gel to Epiduo® Forte Gel and Vehicle Gel (NCT04892706) | Bausch Health Americas, Inc. | 2021-06-11 |
| Study to Evaluate the Safety and Efficacy of VIRAZOLE® in Hospitalized Adult Participants With Respiratory Distress Due to COVID-19_#2 (NCT04356677) | Bausch Health Americas, Inc. | 2021-05-01 |
| A Safety and Pharmacokinetics Study of IDP-118 Lotion in Pediatric Participants With Plaque Psoriasis (NCT03988439) | Bausch Health Americas, Inc. | 2021-03-24 |
| Safety, Tolerability, and Pharmacokinetics of Inhaled Virazole Administered Via Air-Jet Nebulizer in Healthy Volunteers (NCT05229510) | Bausch Health Americas, Inc. | 2021-03-12 |
| Study to Evaluate the Safety and Efficacy of VIRAZOLE® in Hospitalized Adult Participants With Respiratory Distress Due to COVID-19 (NCT04551768) | Bausch Health Americas, Inc. | 2021-02-10 |
| Randomised, Placebo-controlled Safety and Pharmacokinetics Study of Novel Rifaximin Formulations in Healthy Volunteers (NCT04529811) | Bausch Health Americas, Inc. | 2020-09-24 |
| An Extension Study of Methylnaltrexone Bromide (MNTX) in Participants With Advanced Pancreatic Cancer (NCT04151719) | Bausch Health Americas, Inc. | 2020-02-03 |
| Clinical Study Comparing the Efficacy and Safety of IDP-126 Gel in the Treatment of Acne Vulgaris (NCT04214652) | Bausch Health Americas, Inc. | 2020-01-27 |
| Clinical Study Comparing the Efficacy and Safety of IDP-126 Gel in the Treatment of Acne Vulgaris (NCT04214639) | Bausch Health Americas, Inc. | 2020-01-17 |
| A Study of Methylnaltrexone Bromide (MNTX) in Participants With Advanced Pancreatic Cancer (NCT04083651) | Bausch Health Americas, Inc. | 2020-01-06 |
| A Safety and Pharmacokinetics Study of IDP-122 Lotion in Pediatric Participants With Plaque Psoriasis (NCT03987763) | Bausch Health Americas, Inc. | 2019-10-22 |
| A Study to Assess the Efficacy and Safety of Salix Probiotic Blend in Participants With Functional Gastrointestinal Disturbances (NCT04155801) | Bausch Health Americas, Inc. | 2019-10-11 |
| A Study of Brodalumab (SILIQ®) in Psoriasis Participants With Inadequate Response to Their Current Biologic Agent Regimen (NCT04149587) | Bausch Health Americas, Inc. | 2019-09-30 |
| Steady-State Pharmacokinetics of Rifaximin 550 mg Tablets in Healthy and Hepatically Impaired Subjects (NCT03818672) | Bausch Health Americas, Inc. | 2019-01-29 |
| Study Comparing the Safety and Efficacy of IDP-120 Gel and IDP-120 Vehicle Gel in the Treatment of Acne Vulgaris (NCT03664752) | Bausch Health Americas, Inc. | 2018-12-10 |
| Study Comparing the Safety and Efficacy of IDP-120 Gel and IDP-120 Vehicle Gel in the Treatment of Acne Vulgaris (NCT03664739) | Bausch Health Americas, Inc. | 2018-12-05 |
| Rifaximin Soluble Solid Dispersion (SSD) Tablets Plus Lactulose for the Treatment of Overt Hepatic Encephalopathy (OHE) (NCT03515044) | Bausch Health Americas, Inc. | 2018-09-13 |
| Efficacy and Safety of IDP-124 Lotion for the Treatment of Moderate to Severe Atopic Dermatitis in Pediatric and Adult Subjects (NCT03058783) | Bausch Health Americas, Inc. | 2018-08-14 |
| Open-Label, Randomized Study Evaluating the Absorption and Systemic Pharmacokinetics of Topically Applied IDP-126 Gel in Comparison With Control Gel (NCT03653403) | Bausch Health Americas, Inc. | 2018-08-08 |
| Efficacy and Safety of IDP-124 Lotion for the Treatment of Moderate to Severe Atopic Dermatitis in Pediatric and Adult Subjects (301) (NCT03002571) | Bausch Health Americas, Inc. | 2018-07-24 |
| Efficacy and Safety of Plecanatide in Children 6 to <18 Years With Irritable Bowel Syndrome With Constipation (IBS-C) (NCT03596905) | Bausch Health Americas, Inc. | 2018-06-30 |
| A Postmarketing Study of Plecanatide in Breast Milk of Lactating Women Treated With TRULANCE® (NCT03551873) | Bausch Health Americas, Inc. | 2018-06-21 |
| A Phase 2, Multicenter, Randomized, Double-Blind, Vehicle Controlled, Parallel-Group, Clinical Study in the Treatment of Acne Vulgaris (NCT03170388) | Bausch Health Americas, Inc. | 2017-10-05 |